Log In
BCIQ
Print this Print this
 

FCR001

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCell therapy inducing stable donor chimerism and immunological tolerance
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase II
Standard IndicationRenal transplant
Indication DetailsTreat renal transplant
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today